KRAS and colonic neoplasm: Studies in colon cancer cell lines demonstrated that the active K-RAS G13D mutant causes a profound disruption of actomyosin structures, such as stress fibers, and decreases NM II activity even in the presence of a high level of active RhoA [15,79,80].